
    
      The objective of this study is to characterize key aspects of the clinical presentation,
      disease phenotype and progression of patients with late onset Lysosomal Acid Lipase (LAL)
      Deficiency/ Cholesteryl Ester Storage Disease (CESD) including, but not limited to, age of
      presentation, onset of hepatomegaly, progression over time of liver function, and stability
      of lipid abnormalities.
    
  